Dengue virus: epidemiology, biology, and disease aetiology
- PMID: 34171205
- DOI: 10.1139/cjm-2020-0572
Dengue virus: epidemiology, biology, and disease aetiology
Abstract
Dengue is a vector-borne viral disease caused by the flavivirus dengue virus (DENV). Approximately 400 million cases and 22 000 deaths occur due to dengue worldwide each year. It has been reported in more than 100 countries in tropical and subtropical regions. A positive-stranded enveloped RNA virus (DENV) is principally transmitted by Aedes mosquitoes. It has four antigenically distinct serotypes, DENV-1 to DENV-4, with different genotypes and three structural proteins and seven non-structural proteins. Clinical symptoms of dengue range from mild fever to severe dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS), with thrombocytopenia, leucopenia, and increased vascular permeability. Although primary infection causes activation of immune responses against DENV serotypes, the severity of the disease is enhanced via heterotypic infection by various serotypes as well as antibody-dependent enhancement (ADE). The first licensed DENV vaccine was tetravalent CYD Denvaxia, but it has not been approved in all countries. The lack of a suitable animal model, a proper mechanistic study in pathogenesis, and ADE are the main hindrances in vaccine development. This review summarizes the current knowledge on DENV epidemiology, biology, and disease aetiology in the context of prevention and protection from dengue virus disease.
Keywords: ADE; DENV; DHF; antibody-dependent enhancement; dengue hemorrhagic fever; dengue virus; infection secondaire; secondary infection; virus de la dengue.
Similar articles
-
Progress towards understanding the pathogenesis of dengue hemorrhagic fever.Virol Sin. 2017 Feb;32(1):16-22. doi: 10.1007/s12250-016-3855-9. Epub 2016 Nov 14. Virol Sin. 2017. PMID: 27853992 Free PMC article. Review.
-
Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.Antiviral Res. 2013 Jun;98(3):423-31. doi: 10.1016/j.antiviral.2013.03.018. Epub 2013 Mar 29. Antiviral Res. 2013. PMID: 23545366
-
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.Front Cell Infect Microbiol. 2020 Oct 22;10:572681. doi: 10.3389/fcimb.2020.572681. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33194810 Free PMC article. Review.
-
A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.PLoS Med. 2009 Oct;6(10):e1000171. doi: 10.1371/journal.pmed.1000171. Epub 2009 Oct 27. PLoS Med. 2009. PMID: 19859541 Free PMC article. Clinical Trial.
-
An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.J Virol. 2017 Nov 14;91(23):e01181-17. doi: 10.1128/JVI.01181-17. Print 2017 Dec 1. J Virol. 2017. PMID: 28956764 Free PMC article.
Cited by
-
Perinatal Transmission of Dengue Infection among Dengue Hemorrhagic Fever Outbreaks in Southern Vietnam: The First Case Managed at Tu Du Hospital and Review of Literature.Am J Trop Med Hyg. 2022 Nov 14;108(1):155-160. doi: 10.4269/ajtmh.22-0572. Print 2023 Jan 11. Am J Trop Med Hyg. 2022. PMID: 36375466 Free PMC article. Review.
-
Transaminitis among Patients with Dengue Fever Visiting a Tertiary Care Centre.JNMA J Nepal Med Assoc. 2023 Sep 1;61(265):683-686. doi: 10.31729/jnma.8258. JNMA J Nepal Med Assoc. 2023. PMID: 38289802 Free PMC article.
-
Diagnosis of Dengue Virus Infections Imported to Hungary and Phylogenetic Analysis of Virus Isolates.Diagnostics (Basel). 2023 Feb 24;13(5):873. doi: 10.3390/diagnostics13050873. Diagnostics (Basel). 2023. PMID: 36900018 Free PMC article.
-
Dengue infection: Global importance, immunopathology and management.Clin Med (Lond). 2022 Jan;22(1):9-13. doi: 10.7861/clinmed.2021-0791. Clin Med (Lond). 2022. PMID: 35078789 Free PMC article.
-
Comparative phylogenetic analysis and transcriptomic profiling of Dengue (DENV-3 genotype I) outbreak in 2021 in Bangladesh.Virol J. 2023 Jun 19;20(1):127. doi: 10.1186/s12985-023-02030-1. Virol J. 2023. PMID: 37337232 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical